United States Off Label Drugs Market 2015 Analysis & 2020 Forecasts in New Research Report at RnRMarketResearch.com

News provided by

Apr 14, 2015, 12:00 ET

DALLAS, April 14, 2015 /PRNewswire/ --

RnRMarketResearch.com adds United States Off-Label Drugs Market & Forecast research of 67 pages, published in April 2015, to the Prescription Drugs intelligence collection of its store.

"United States Off-Label Drugs Market & Forecast" report provides a comprehensive analysis of the emerging Off-Label Drugs market. The report also entails commonly prescribed Off-Label Drugs, Perspective of Physicians, Patients, Pharmaceutical Companies and Regulatory Authorities, Off-label Promotion Settlements under the False Claims Act. The report also studies Drivers and Challenges of United States Off-Label Drugs market. This 67 page report with 16 Figures and

Table studies 6 Off-Label Drugs Segment.

The 6 Off-Label Drugs Segment Covered in the Report are as Follows:

Cancer Off-Label Drugs, Central Nervous System (CNS) Off-Label Drugs, Anti-Ashmatics Off-Label Drugs, Anti-Allergies Off-Label Drugs, Anti-Hypertensives Off-Label Drugs, Anti-Infectives Off-Label Drugs. Order a copy of this report (United States Off-Label Drugs Market & Forecast) at http://www.rnrmarketresearch.com/contacts/purchase?rname=351522 .

Major Points from Table of Contents

List of Figures

Figure 2-1: United States - Off-Label Drugs Market (Billion US$), 2011 - 2014
Figure 2-2: United States - Forecast for Off-Label Drugs Market (Billion US$), 2015 - 2020
Figure 3-1: United States - Off-Label Drugs Market Share (Percent), 2011 - 2014
Figure 3-2: United States - Forecast for Off-Label Drugs Market Share (Percent), 2015 - 2020
Figure 4-1: United States - Cancer Off-Label Drugs Market (Billion US$), 2008 - 2014
Figure 4-2: United States - Forecast for Cancer Off-Label Drugs Market (Billion US$), 2015 - 2020
Figure 4-3: United States - Central Nervous System (CNS) Off-Label Drugs Market (Billion US$), 2009 - 2014
Figure 4-4: United States - Forecast for Central Nervous System (CNS) Off-Label Drugs Market (Billion US$), 2015 - 2020
Figure 4-5: United States - Anti-Ashmatics Off-Label Drugs Market (Billion US$), 2010 - 2014
Figure 4-6: United States - Forecast for Anti-Ashmatics Off-Label Drugs Market (Billion US$), 2015 - 2020
Figure 4-7: United States - Anti-Allergies Off-Label Drugs Market (Billion US$), 2011 - 2014
Figure 4-8: United States - Forecast for Anti-Allergies Off-Label Drugs Market (Billion US$), 2015 - 2020
Figure 4-9: United States - Anti-Hypertensives Off-Label Drugs Market (Billion US$), 2009 - 2014
Figure 4-10: United States - Forecast for Anti-Hypertensives Off-Label Drugs Market (Billion US$), 2015 - 2020
Figure 4-11: United States - Anti-Infectives Off-Label Drugs Market (Billion US$), 2008 - 2014
Figure 4-12: United States - Forecast for Anti-Infectives Off-Label Drugs Market (Billion US$), 2015 - 2020

Related Market Reports on "Prescription Drugs"

According to hospital terminal data, Chinese patent medicine for the treatment of cardiovascular and cerebrovascular diseases, tumor diseases and respiratory system diseases are the top three categories of Chinese patent medicine in China, respectively accounting for 37.2%, 15.4% and 11.1% market share in 2012-2013. As far as the distribution of Chinese patent medicine formulations is concerned, there is a clear trend of convergence in injection, and injection formulation products in the top three categories of Chinese patent medicine all made up above 50%.

Cardiovascular and cerebrovascular disease market is the biggest market for Chinese patent medicine, but also the most-variety field with item sales of over RMB500 million. The representative products include ginkgo leaf injection, Shuxuetong injection, Danhong injection, Xingnao injection, and more.

In the international market, there is a higher recognition of Chinese patent medicine in Asia, especially in Southeast Asia, and many varieties of Chinese patent medicine are included in the Medicare drug list stipulated by Southeast Asian countries, and special departments are established for management research as well. But in the U.S. and European markets, affected by access restrictions and differences in medical health concept, Chinese patent medicine is still only sold as health care product. However, the international market sees strong demand for plant extracts (mostly traditional Chinese medicinal materials) whose export value in 2010-2013 grew at a CAGR of 44% and accounted for approximately 50% of China's TCM export value.

Currently, the State is enhancing its support for the Chinese patent medicine industry, successively introducing the Continuing Improving TCM Healthcare Policy, Notice on Conducting Construction of Key Projects of TCM Trade in Services and other favorable policies in 2013. In 2010-2013, China's Chinese patent medicine industry developed rapidly, with revenue soaring from RMB215.4 billion to RMB448.2 billion at a CAGR of 27.7%.

Market Research Report on Global and Chinese Bimatoprost Industry, 2009-2019 (http://www.rnrmarketresearch.com/market-research-report-on-global-and-chinese-bimatoprost-industry-2009-2019-market-report.html) is a professional and in-depth market survey on Global and Chinese Bimatoprost industry. The report firstly reviews the basic information of Bimatoprost including its classification, application and manufacturing technology. The report then explores global and China's top manufacturers of Bimatoprost listing their product specification, capacity, Production value, and market share etc. The report further analyzes quantitatively 2009-2014 global and China's total market of Bimatoprost by calculation of main economic parameters of each company. The breakdown data of Bimatoprost market are presented by company, by country, and by application. The report also estimates 2014-2019 market development of Bimatoprost Industry. The report then analyzes the upstream raw materials, downstream clients, and current market dynamics of Bimatoprost Industry. In the end, the report makes some proposals for a new project of Bimatoprost Industry and a new project of Bimatoprost Industry before evaluating its feasibility. Overall, the report provides an in-depth insight of 2009-2014 global and China Bimatoprost industry covering all important parameters.

Browse more reports on "Prescription Drugs" at

http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/prescription-drugs .

About Us:

RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Connect with Us:

G+ / Google Plus: https://plus.google.com/u/0/104156468549256253075/

Twitter: https://twitter.com/RnRMR

Facebook: https://www.facebook.com/pages/RnR-Market-Research/413488545356345

RSS / Feeds: http://www.rnrmarketresearch.com/rssfeed-prof-research

Contact:
Ritesh Tiwari
TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252
Tel: +1-888-391-5441
[email protected]

SOURCE RnR Market Research